Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results. - Saeed A; Park R; Dai J; Al-Rajabi R; Kasi A; Baranda J; Williamson S; Ripp J; Collins Z; Mulvaney K; Shugrue M; Firth-Braun J; et al. (Cell reports. Medicine, 2023)